Eastgate Biotech Corp.
ETBI · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $14 | $7 | $1 | $10 |
| - Cash | $0 | $0 | $0 | -$0 |
| + Debt | $5 | $4 | $3 | $2 |
| Enterprise Value | $19 | $11 | $4 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -26.7% | -13.5% | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -110.4% | -50.6% | -1.9% | – |
| EBITDA | -$3 | -$1 | -$3 | -$3 |
| % Margin | -3,107.2% | -907.2% | -2,115% | – |
| Net Income | -$4 | -$1 | -$4 | -$3 |
| % Margin | -3,553.7% | -1,100.3% | -2,363.4% | – |
| EPS Diluted | -0.002 | -0.001 | 0 | -0.01 |
| % Growth | -58.3% | – | 100% | – |
| Operating Cash Flow | $0 | -$0 | -$1 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | -$0 | -$1 | -$0 |